GlassScriptPhysician profile
Andrew Dylan Frutkin
NPI 1407885403
$13,645.89
in general payments reported to CMS, 2019-2025
14 companies · $3,313 in 2025
The $3,313 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,891 · 2020: $1,172 · 2021: $1,097 · 2022: $2,046 · 2023: $1,048 · 2024: $3,078 · 2025: $3,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,469 · Travel and Lodging: $970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,468.64 |
| Travel and Lodging | $970.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $9,122.64 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Abbott Laboratories | $3,367.96 | 2019-2025 | Mitraclip, Xience Skypoint, Triclip |
| Abiomed | $546.55 | 2019-2024 | Impella |
| Atricure, INC. | $124.23 | 2023 | |
| Cardiovascular Systems INC. | $119.42 | 2020-2021 | |
| Philips North America LLC | $104.05 | 2020-2023 | |
| Siemens Medical Solutions USA, INC. | $76.49 | 2023 | Artis Icono Floor |
| Lantheus Medical Imaging, INC. | $49.14 | 2024 | |
| Chiesi USA, INC. | $33.78 | 2022-2025 | Cleviprex, Kengreal |
| Ge Healthcare | $25.41 | 2023 | |
| Novartis Pharmaceuticals Corporation | $23.15 | 2022 | |
| Cathworks, INC. | $21.38 | 2022 | |
| Cardiva Medical, INC. | $18.71 | 2024 | Savvywire |
| Astrazeneca Pharmaceuticals LP | $12.98 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Frutkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.